Reusability report: Evaluating reproducibility and reusability of a fine-tuned model to predict drug response in cancer patient samples

No abstract is available for this paper.

• Publication year

  2023

• Venue

  Nature Machine Intelligence

• Publication date

  2023-07-01

• Fields of study

  Medicine, Computer Science

• Identifiers
  DOI 10.1038/s42256-023-00688-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating Small EVs miRNAs as Predictors of Pathological Response to Neo-Adjuvant Therapy in Breast Cancer Patients

  2022cited by this paper
• Computational estimation of quality and clinical relevance of cancer cell lines

  2022cited by this paper
• Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients

  2021influential reference
• Evaluation of statistical approaches for association testing in noisy drug screening data

  2021cited by this paper
• Orchestrating and sharing large multimodal data for transparent and reproducible research

  2021cited by this paper
• Research Reproducibility as a Survival Analysis

  2020cited by this paper
• Computational Reproducibility via Containers in Psychology

  2019cited by this paper
• Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer

  2018cited by this paper
• Gene isoforms as expression-based biomarkers predictive of drug response in vitro

  2017cited by this paper
• A Landscape of Pharmacogenomic Interactions in Cancer

  2016cited by this paper
• A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds

  2016cited by this paper
• Reproducible pharmacogenomic profiling of cancer cell line panels

  2016cited by this paper
• Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset.

  2015cited by this paper
• Revisiting inconsistency in large pharmacogenomic studies

  2015influential reference
• High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

  2015cited by this paper
• Estrogen receptor (ER) mRNA expression and molecular subtype distribution in ER-negative/progesterone receptor-positive breast cancers

  2014cited by this paper
• Biomarker Analysis of Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early-Stage Breast Cancer

  2013cited by this paper
• Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

  2012cited by this paper
• The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity

  2012influential reference
• A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

  2011cited by this paper

• The Hallmarks of Predictive Oncology.

  2025cites this paper
• Predicting gene essentiality and drug response from perturbation screens in preclinical cancer models with LEAP: Layered Ensemble of Autoencoders and Predictors

  2025cites this paper
• DTLCDR: A target-based multimodal fusion deep learning framework for cancer drug response prediction

  2025cites this paper
• Assessing Reusability of Deep Learning-Based Monotherapy Drug Response Prediction Models Trained with Omics Data

  2024cites this paper
• Artificial intelligence in food and nutrition evidence: The challenges and opportunities

  2024cites this paper